Epidemiology and clinical manifestations of Leishmania donovani infection in two villages in an endemic area in eastern Sudan.
about
Role of the domestic dog as a reservoir host of Leishmania donovani in eastern SudanImmunogenicity and immune modulatory effects of in silico predicted L. donovani candidate peptide vaccinesA screen-and-treat strategy targeting visceral leishmaniasis in HIV-infected individuals in endemic East African countries: the way forward?Who is a typical patient with visceral leishmaniasis? Characterizing the demographic and nutritional profile of patients in Brazil, East Africa, and South AsiaIncidence of symptomatic and asymptomatic Leishmania donovani infections in high-endemic foci in India and Nepal: a prospective study.Y chromosome lineage- and village-specific genes on chromosomes 1p22 and 6q27 control visceral leishmaniasis in Sudan.Classification and regression tree and spatial analyses reveal geographic heterogeneity in genome wide linkage study of Indian visceral leishmaniasis.Burden of visceral leishmaniasis in villages of eastern Gedaref State, Sudan: an exhaustive cross-sectional survey.Genetic and functional evidence implicating DLL1 as the gene that influences susceptibility to visceral leishmaniasis at chromosome 6q27.The economic value of a visceral leishmaniasis vaccine in Bihar state, India.Eco-epidemiology of visceral leishmaniasis in Ethiopia.Asymptomatic leishmaniasis in kala-azar endemic areas of Malda district, West Bengal, India.Cutaneous Infection with Leishmania major Mediates Heterologous Protection against Visceral Infection with Leishmania infantumCommon variants in the HLA-DRB1-HLA-DQA1 HLA class II region are associated with susceptibility to visceral leishmaniasis.Inherited human OX40 deficiency underlying classic Kaposi sarcoma of childhood.Safety and Effectiveness of Sodium Stibogluconate and Paromomycin Combination for the Treatment of Visceral Leishmaniasis in Eastern Africa: Results from a Pharmacovigilance ProgrammeConcomitant Infection with Leishmania donovani and L. major in Single Ulcers of Cutaneous Leishmaniasis Patients from Sudan.Current diagnosis and treatment of visceral leishmaniasis.Recombinant K39 immunochromatographic test for diagnosis of human leishmaniasis.Interleukin 10 gene polymorphisms and development of post kala-azar dermal leishmaniasis in a selected sudanese populationMicroalbuminuria and glomerular filtration rate in paediatric visceral leishmaniasis.Efficacy of liposomal amphotericin B (AmBisome) in the treatment of persistent post-kala-azar dermal leishmaniasis (PKDL).Combining epidemiology with basic biology of sand flies, parasites, and hosts to inform leishmaniasis transmission dynamics and control.Immune Checkpoint Targets for Host-Directed Therapy to Prevent and Treat Leishmaniasis.Dichotomy of protective cellular immune responses to human visceral leishmaniasis.Immunochemotherapy of persistent post-kala-azar dermal leishmaniasis: a novel approach to treatment.Revival of a focus of visceral leishmaniasis in central Sudan.Visceral leishmaniasis in selected communities of Hamar and Banna-Tsamai districts in Lower Omo Valley, South West Ethiopia: Sero-epidemological and Leishmanin Skin Test Surveys.
P2860
Q21198938-15549527-199C-4CD6-AD7B-AF7A241DB65CQ28273639-3FB681C9-F5CD-43C7-A205-9B15D668450AQ28541690-ADC156AE-DABD-416A-8916-8B4652FD6F87Q28741732-5FAD5257-0029-4B91-B3F4-9A9CAABABE1AQ31032931-D32CD509-1E75-411F-B702-F0BE362346F2Q33284534-9C70C83E-10DA-404D-AD57-03F9ADD682DEQ33786681-66B6A35E-15C3-47C5-8285-05A4EF449E02Q34469976-F36E57AA-134C-45CE-8746-942308E556C0Q35093302-14B1904B-2364-4C1A-876A-72531E4BBB78Q35771782-E4A4A6A0-8D67-41F3-AFEA-1D4889107919Q35863732-45DA9CF4-266E-4089-A61B-338D65EFBB27Q36277146-C5A6D752-A22A-426B-B6D5-5296F8ABB6BEQ36331305-6BED08C2-ACE8-4162-AE1E-6BE572F5F740Q36875283-D4BD5D41-382A-495F-A419-D4C8F897299AQ37125732-1B2CCDF7-0532-46E5-987E-9CAA1B9D12F6Q37650681-4562E32F-9453-49BA-845B-7C4DBBBEF957Q37679657-D2A56641-9129-46C5-9D4F-A9EA7CEA8978Q37778829-98A0F2A2-64AD-4A72-A111-9A20080F0443Q39997884-73783E04-DA02-4077-8C0A-5DD971232F47Q41830302-B585B992-2072-40DB-8900-54098036F6E6Q43100670-794EB8B5-5147-4476-BAF5-18F730448FBAQ44884159-85FBF272-9575-493C-A7E5-6A9E622F091FQ45980979-581DDE17-0859-4A05-863F-B9CA78A716A2Q46080853-038A1D34-9C5C-412E-B11E-CBB4E4CBEFC1Q46589097-F535D73F-FD98-4EF0-93E1-0DBBBDA547F2Q51902268-73167AA2-9405-4B1D-99EC-B921D8807E73Q52687663-4222E25E-29BC-46EF-94B3-38BE854C4818Q55114618-3E741A41-3353-4F0E-B5B4-36197949F768
P2860
Epidemiology and clinical manifestations of Leishmania donovani infection in two villages in an endemic area in eastern Sudan.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Epidemiology and clinical mani ...... endemic area in eastern Sudan.
@en
Epidemiology and clinical mani ...... endemic area in eastern Sudan.
@nl
type
label
Epidemiology and clinical mani ...... endemic area in eastern Sudan.
@en
Epidemiology and clinical mani ...... endemic area in eastern Sudan.
@nl
prefLabel
Epidemiology and clinical mani ...... endemic area in eastern Sudan.
@en
Epidemiology and clinical mani ...... endemic area in eastern Sudan.
@nl
P2093
P2860
P1476
Epidemiology and clinical mani ...... endemic area in eastern Sudan
@en
P2093
A M El Hassan
E E Zijlstra
P2860
P356
10.1046/J.1365-3156.2002.00832.X
P50
P577
2002-01-01T00:00:00Z